New hope for bald spots: drug trial targets severe hair loss
NCT ID NCT07311564
First seen Jan 04, 2026 · Last updated May 22, 2026 · Updated 22 times
Summary
This study tests a new drug called LAD603 for adults with severe to very severe alopecia areata, a condition causing major hair loss on the scalp. About 136 people will receive either the drug or a placebo to see if it helps hair regrow and is safe. The main goal is to measure changes in hair loss using a special scoring tool.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALOPECIA AREATA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Investigator Site 1
RECRUITINGOmaha, Nebraska, 68144, United States
Conditions
Explore the condition pages connected to this study.